Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 12:45 pm Unchanged | 2026-02-28 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-03-03 5:27 pm Unchanged | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-03-03 5:25 pm Sale | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -3,016,026 (Position Closed) | Filing History |
| 2026-02-11 10:57 am Purchase | 2025-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,016,026 6.040% | 405,689 (+15.54%) | Filing History |
| 2026-02-11 10:57 am Sale | 2025-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 5,185,696 8.480% | -342,543 (-6.20%) | Filing History |
| 2025-03-05 2:16 pm Sale | 2025-02-28 | 13G | FLYWIRE CORP COM VTG FLYW | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -6,516,044 (Position Closed) | Filing History |
| 2025-02-11 09:15 am Purchase | 2024-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 5,528,239 9.180% | 1,453,025 (+35.66%) | Filing History |
| 2025-02-11 09:12 am Sale | 2024-12-31 | 13G | INNOVIVA INC INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -4,106,136 (Position Closed) | Filing History |
| 2025-02-11 09:11 am Purchase | 2024-12-31 | 13G | FLYWIRE CORP COM VTG FLYW | WESTFIELD CAPITAL MANAGEMENT CO LP | 6,516,044 5.320% | 6,516,044 (New Position) | Filing History |
| 2025-02-11 09:09 am Purchase | 2024-12-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | WESTFIELD CAPITAL MANAGEMENT CO LP | 2,610,337 5.490% | 2,610,337 (New Position) | Filing History |
| 2025-02-10 5:13 pm Purchase | 2024-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,075,214 9.180% | 44,580 (+1.11%) | Filing History |
| 2024-08-05 1:02 pm Sale | 2024-08-05 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -743,495 (Position Closed) | Filing History |
| 2024-07-08 9:42 pm Sale | 2024-06-28 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | WESTFIELD CAPITAL MANAGEMENT CO LP | 743,495 4.390% | -577,052 (-43.70%) | Filing History |
| 2024-05-08 1:49 pm Sale | 2024-04-30 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | WESTFIELD CAPITAL MANAGEMENT CO LP | 1,320,547 7.810% | -227,871 (-14.72%) | Filing History |
| 2024-04-04 8:56 pm Sale | 2024-03-29 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | WESTFIELD CAPITAL MANAGEMENT CO LP | 1,548,418 9.150% | -437,468 (-22.03%) | Filing History |
| 2024-02-02 1:18 pm Purchase | 2023-12-29 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,030,634 7.050% | 872,466 (+27.63%) | Filing History |
| 2024-01-09 8:17 pm Purchase | 2023-12-29 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | WESTFIELD CAPITAL MANAGEMENT CO LP | 1,985,886 11.900% | 1,985,886 (New Position) | Filing History |
| 2023-07-05 12:01 pm Sale | 2023-06-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WESTFIELD CAPITAL MANAGEMENT CO LP | 0 0.000% | -8,145,674 (Position Closed) | Filing History |
| 2023-02-01 7:39 pm Purchase | 2022-12-30 | 13G | INNOVIVA INC INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,106,136 5.880% | 422,651 (+11.47%) | Filing History |
| 2023-02-01 7:36 pm Purchase | 2022-12-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,158,168 5.540% | 3,158,168 (New Position) | Filing History |